Bremelanotide is a synthetic melanocortin receptor agonist. Originally developed as a tanning agent, it is a metabolite of the compound MT-I and was later found to promote sexual function. Unlike most medications for erectile dysfunction in men targeting hemodynamic issues, it regulates libido by acting directly on melanocortin receptors in the central nervous system, particularly the hypothalamus. Its uniqueness lies in the fact that it is neither a hormone nor a nitric oxide pathway-based drug, and it has potential therapeutic effects in both men and women. The drug is administered via subcutaneous injection.
What is Bremelanotide and how does it work?
Bremelanotide is a synthetic melanocortin receptor agonist. Unlike medications that target hemodynamic issues, it regulates libido by acting directly on melanocortin receptors in the central nervous system, particularly the hypothalamus.
How is Bremelanotide administered?
Currently, the drug is administered via subcutaneous injection. While intranasal formulations were previously researched, their development has progressed slowly.
What is the FDA-approved use for Bremelanotide?
In 2019, its branded drug Vyleesi was approved by the U.S. FDA for treating acquired and generalized sexual interest/arousal disorders in premenopausal women.
Can Bremelanotide be used for male erectile dysfunction?
It is a potential treatment area, especially suitable for male patients who do not respond to or cannot use standard drugs (like PDE5 inhibitors) due to contraindications to nitrates, as its mechanism is independent of the nitric oxide pathway.
What are the main side effects and challenges associated with this drug?
The most common side effects include nausea and flushing, along with a risk of increased blood pressure which limits its use for some patients. Additionally, the subcutaneous injection method is less convenient than oral medications.
Does Bremelanotide help with antidepressant-induced sexual dysfunction?
Yes, it is currently being researched as a possible coping strategy for sexual dysfunction side effects caused by SSRIs (antidepressants).